A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability
Paul W. Burridge(Northwestern University), Elias T. Zambidis(Johns Hopkins University)
Cited by 422
Related Papers
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders
|Biology of Blood and Marrow Transplantation|2016|76
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies
|Biology of Blood and Marrow Transplantation|2016|73
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
|Blood Advances|2020|73